Kaiser Permanente Center for Reproductive Health

San Francisco, California 94109

Medical Director: Irene Moy, MD

The Kaiser Permanente Center for Reproductive Health in San Francisco offers comprehensive fertility care under the leadership of Medical Director Dr. Irene Moy. As part of the trusted Kaiser Permanente health system, the center provides a full range of services including IVF, egg freezing, donor egg programs, and surrogacy support. With 508 treatment cycles performed in 2022, the clinic has established itself as an active practice serving the San Francisco Bay Area community.

The center's success rates reflect their commitment to quality care, with live birth rates of 37.20% for patients under 35 and 39.20% for those ages 35-37. Whether you're just beginning to explore fertility options or ready to move forward with treatment, the team understands that this journey can feel overwhelming. Their approach focuses on providing clear guidance and personalized care to help you navigate your path to parenthood with confidence and support.

Services Offered

IVF

In vitro fertilization — eggs are retrieved and fertilized in a lab, then transferred to the uterus.

Egg Freezing

Oocyte cryopreservation — eggs are retrieved and frozen for future use.

Donor Egg

Uses eggs from a screened donor for patients who cannot use their own.

Surrogacy

Gestational carrier arrangements — an embryo is transferred to a surrogate who carries the pregnancy.

Success Rates

Success rates reflect live births per intended egg retrieval, as reported to the CDC for the 2022 reporting year. Rates vary based on individual patient factors.

Age GroupFresh TransfersFrozen TransfersNat'l Avg
Under 3537.20%-11.244.40%48.4%
35–3739.20%+3.264.50%36%
38–4027.80%+4.262.50%23.6%
Over 4016.70%+7.2Not reported9.5%

Based on 508 total cycles reported. National averages computed across all reporting clinics.

Physicians

Nearby Clinics

Data on this page is sourced from the CDC's National ART Surveillance System (NASS) and the Society for Assisted Reproductive Technology (SART). Success rates reflect live births per intended egg retrieval for the 2022 reporting year. Individual results vary based on patient age, diagnosis, and treatment protocol.